Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180 Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes

Hueber, Pierre-Alain; Bienz, Marc; Valdivieso, Roger; Lavigueur-Blouin, Hugo; Misraï, Vincent; Rutman, Matthew P.; Te, Alexis E.; Chughtai, Bilal; Barber, Neil; Emara, Amr; Munver, Ravi; Trinh, Quoc‐Dien; Zorn, Kevin C.

doi:10.1016/j.juro.2015.03.113

Cited by 52 publications

(29 citation statements)

References 19 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vigil, Humberto 1 ; Mallick, Ranjeeta 2 ; Lavallee, Luke T. 1,2 ; Breau, Rodney H. 1,2 ; Hickling, Duane R. Urinary tract infections following midurethral sling (MUS) surgery are common. We sought to determine the incidence of and risk factors for urinary tract infection (UTI) following MUS surgery using a validated, multicentre database.…”

Section: Mp-0804 Risk Factors For Urinary Tract Infection Following mentioning

confidence: 99%

“…1,2 ; Carlson, Kevin V. 1,2 ; Civitarese, Andrea 1 ; Crump, Trafford 1 1 Vesia (Alberta Bladder Centre), Calgary, AB, Canada; 2 Surgery, University of Calgary, Calgary, AB, Canada Introduction and Objectives: Overactive bladder (OAB) is a chronic condition requiring regular management and symptom assessment. Patients with lower urinary tract symptoms, such as OAB, are frequently referred to urology.…”

Section: Mp-0805mentioning

confidence: 99%

“…The ideal amount of energy delivery during photoselective vaporization of the prostate (PVP) for optimal treatment of benign prostate hyperplasia (BPH) has not been established. 1 The aim of this study is to assess the effect of energy density (kJ/cc) applied on adenoma during treatment on functional outcomes, prostate-specific antigen (PSA) reduction, and complications. Methods: After exclusions, a total of 440 patients who underwent Greenlight laser XPS 180 W LBO PVP for the treatment of BPH were retrospectively reviewed.…”

Section: Mp-0811mentioning

confidence: 99%

“…The use of urodynamics in followup of neurogenic bladders treated with onabotulinumtoxinA Bergeron, Michelle 1,2 ; Nadeau, Geneviève 1,2 ; Moore, Katherine 1,2 1 Urology, CHU de Québec, Quebec, QC, Canada; 2 Urology, Institut de réadaptation en déficience physique de Québec, Quebec, QC, Canada Introduction and Objectives: Patients with neurologic disorders may suffer from detrusor overactivity (NDO) or low bladder compliance, which can damage the upper urinary tract. Intradetrusor injections of onabotulinumtoxinA (BoNTA) have recently emerged as a treatment for NDO.…”

Section: Up-0801mentioning

confidence: 99%

“…1,2 ; Carlson, Kevin V. 1,2 ; Civitarese, Andrea1; Crump, Trafford 1 1 Vesia (Alberta Bladder Centre), Calgary, AB, Canada; 2 Surgery, University of Calgary, Calgary, AB, Canada Introduction and Objectives: Treating urinary incontinence (UI) is difficult due to the quality of life impact of the patient's symptoms, but also the side effects of treatment options themselves. Patient-reported outcomes (PROs) are a way to quantify this impact and incorporate it into clinical practice.…”

Section: Up-0802mentioning

confidence: 99%

See 4 more Smart Citations

Poster Session 8: Functional Urology

Editorial¹

2016

CUAJ

View full text Add to dashboard Cite

Introduction and Objectives:Patients diagnosed with interstitial cystitis/ bladder pain syndrome (IC/BPS) represent a heterogeneous group of clinical phenotypes. The presence of Hunner's lesions presents an opportunity for objective classification into those with Hunner's lesion IC/BPS (classic IC) and those with non-Hunner's lesion BPS. While currently, a diagnosis of Hunner's lesion IC/BPS requires cystoscopy, limited data exist suggesting that these subtypes can be distinguished without endoscopic examination based on the degree of bladder-focused centricity and infrequent association with generalized pain conditions. Methods: Patients from a prospective, single-centre database of IC/BPS patients who had documented cystoscopic findings were categorized as those with Hunner's lesion IC/BPS and non-Hunner's lesion BPS. Their demographics, pain and symptom scores, voiding symptoms, presence of IBS, and clinical UPOINT scoring were comparatively analyzed. Results: A total of 469 patients were reviewed. Of those, 359 had documented local anesthetic cystoscopic findings; 44 (12.3%) with Hunner's lesion IC/BPS and 315 (87.7%) with non-Hunner's BPS. Patients with Hunner's lesions were older (p=0.004), had greater urinary frequency (p=0.013), more nocturia (p=0.0004), and higher ICSI scores (p=0.017). There was no difference in number of UPOINT phenotype domains reported, overall UPOINT scores or prevalence of IBS between the groups. Conclusions: A subtype of IC with Hunner's lesions has worse bladdercentric symptoms, but did not have a distinct bladder-centric phenotype. Given the management implications of distinguishing classic IC from nonHunner's lesion BPS, we recommend routine cystoscopy with local anesthesia for all patients with a suspected diagnosis of IC/BPS. 3 Medicine, Dalhousie University, Halifax, NS, Canada; 4 Surgery, University of Toronto, Toronto, ON, Canada Introduction and Objectives: Several small studies suggest prostate cancer treatment, including radical prostatectomy (RP) and radiation (XRT), may be associated with the development of overactive bladder (OAB). The rate of OAB following treatment for prostate cancer has not yet been investigated at the population level. The purpose of this study was to determine the proportion of men who are prescribed anticholinergic medications after being treated for prostate cancer with radiation compared to surgery, as a marker of estimating the proportion of men with OAB following treatment of prostate cancer. MP-08.02 Prescription of anticholinergic medication following treatment of localized prostate cancer Methods:We conducted a population-based, retrospective cohort study comparing men treated for localized prostate cancer with XRT to men treated with RP between 1997 and 2012 in Ontario, Canada. Hospital administrative data and data from the Ontario Cancer Registry (OCR) and the Ontario Drug Benefit (ODB) plan were used. The primary outcome was the prescription of an anticholinergic medication (Ach) after the completion of prostate cancer treatment def...

show abstract

Section: Mp-0804 Risk Factors For Urinary Tract Infection Following mentioning

confidence: 99%

Section: Mp-0805mentioning

confidence: 99%

Section: Mp-0811mentioning

confidence: 99%

Section: Up-0801mentioning

confidence: 99%

“…1,2 ; Carlson, Kevin V. 1,2 ; Civitarese, Andrea1; Crump, Trafford 1 1 Vesia (Alberta Bladder Centre), Calgary, AB, Canada; 2 Surgery, University of Calgary, Calgary, AB, Canada Introduction and Objectives: Treating urinary incontinence (UI) is difficult due to the quality of life impact of the patient's symptoms, but also the side effects of treatment options themselves. Patient-reported outcomes (PROs) are a way to quantify this impact and incorporate it into clinical practice.…”

Section: Up-0802mentioning

confidence: 99%

See 3 more Smart Citations